#ASCO26 is in full swing and it’s been great connecting with so many teams across the industry. The conversations have been thoughtful, honest and focused on the real work behind moving studies forward. Stop by booth 36069, we’d welcome the chance to connect.
IQVIA Research & Development Solutions
Research Services
Durham, NC 91,610 followers
Using intelligent connections to accelerate your clinical trials without compromise.
About us
IQVIA Research & Development Solutions (RDS) is the full-service clinical development partner that leverages the power of IQVIA Connected Intelligence across your entire study, from study design to site selection, enrollment and execution, so you can deliver life-changing therapies faster and without compromise.
- Website
-
https://www.iqvia.com/solutions/research-and-development
External link for IQVIA Research & Development Solutions
- Industry
- Research Services
- Company size
- 10,001+ employees
- Headquarters
- Durham, NC
Updates
-
Kicking off #ASCO26 Annual Meeting with our team onsite. Come visit us at booth 36069 and let’s start planning your oncology program.
-
-
Turning patient insight into execution that works for sites is one of the biggest challenges in obesity trials. This on-demand webinar breaks down how to operationalize patient insights, reduce site friction, and strengthen recruitment and retention, practically and at scale. Find the link to the recording in the comment section!
-
Determine your molecule’s potential faster, with the right early phase partner. At IQVIA, we have an extensive global capacity to quickly and efficiently identify the right subjects, dose/exposure, therapeutic response, and overall commercial strategy, so that your team can accelerate to the next stage with confidence. Learn more about IQVIA's early phase clinical trial expertise here: https://bit.ly/3RPbQQZ
-
-
Project FrontRunner is prompting a shift in how teams plan for early line oncology trials, with new considerations across endpoints, dose optimization, and regulatory engagement. Learn what this means for sponsors and patients in our white paper: https://bit.ly/3O3Z8vT
-
𝗪𝗲𝗲𝗸𝗹𝘆 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 𝗦𝗲𝗿𝗶𝗲𝘀 Clinical research has traditionally been done to and for patients, but not always with them. That’s changing. Patients are increasingly seen as active partners in research, bringing lived experience that can shape smarter trial design, improve recruitment, and support outcomes that actually matter to those living with the disease. When patient voice is incorporated early and proactively, studies are more likely to stay on track, require fewer amendments, and deliver with greater efficiency. It’s about listening and applying those insights in ways that reduce burden and make participation more realistic. If patients are no longer passengers but rather co-pilots in clinical research, how early are their perspectives being meaningfully integrated into your trial planning?
-
Make the most of AI. Join IQVIA’s Vice President of Machine Learning, Raja Shankar, at #DIA2026 for a session on how advanced AI can improve trial design, streamline execution and support faster, more confident decisions for sponsors. See you on June 15 at 10:15 a.m., Innovation Theater 1.
-
-
In obesity and metabolic research, smoother study start-up can help teams maintain momentum from day one. The IQVIA Obesity Site Network gives sponsors access to actively curated sites with operational readiness designed to support faster study start-up and diverse obesity patient populations, including those living with type 2 diabetes and related metabolic conditions. Read the fact sheet to learn more about our approach: https://bit.ly/4tCYQex
-
We are pleased to be on the ground at Global Clinical Trials Connect 2026, hosted by Corvus Global Events. This year’s conference will take a deep dive into enhancing trial efficiency, regulatory compliance, patient safety and technological adoption. We look forward to connecting with industry colleagues to explore how IQVIA Healthcare-grade AI® and our linguistic experts support compliant, patient-centric clinical operations worldwide. Our comprehensive Language Solutions accelerate global clinical trials by enabling faster patient recruitment, earlier regulatory submissions and reduced rework across regions. Visit our experts, Ruyana Dassu, Emi Pell and Astrid QUINTO, at the IQVIA booth to find out how we can support your global trials. https://bit.ly/4u3Ph8K
-
-
The complexities of conducting clinical studies are set to rise in the coming years. So, what's the best step forward? Partnering with the right Functional Service Provider (FSP). Read our white paper with insights from IQVIA expert Ian Pemberton to learn how effective partnerships can help you bring life changing treatments to market faster. https://bit.ly/4thUXMV
-